ESCRS - Ray tracing-based power calculation leads to better refractive outcomes ;
ESCRS - Ray tracing-based power calculation leads to better refractive outcomes ;

Ray tracing-based power calculation leads to better refractive outcomes

More individual IOL power calculation is possible, for example in eyes with irregular cornea or those eyes who have previously undergone refractive surgery.

Ray tracing-based power calculation leads to better refractive outcomes
Leigh Spielberg
Leigh Spielberg
Published: Friday, October 13, 2017
Nino Hirnschall MD Nino Hirnschall, Vienna Institute for Research in Ocular Surgery, Austria, said there are two potential advantages of a ray tracing-based IOL power calculation. “First, more individual IOL power calculation is possible, for example in eyes with irregular cornea or those eyes who have previously undergone refractive surgery. Second, because it is a purely physical approach, no empirical ‘optimisation’ is required,” said Dr Hirnschall. In the ray tracing-based method, IOL selection is based on predicted visual acuity and a neuronal weighted retinal image quality metric (RIQM). It involves ssOCT-based biometry and keratometry, incorporating anterior and posterior corneal surfaces, corneal thickness, axial length, anterior chamber depth and white-to-white distance. Dr Hirnschall’s team conducted a prospective study of 40 eyes comparing outcomes obtained using the ray tracing method with those obtained with a triple-optimised Haigis formula. “Ray tracing offers more detailed information of the cornea, as well as anatomical data instead of estimated lens position, both of which lead to a better refractive outcome,” said Dr Hirnschall. A potential limitation of the method is that exact IOL design information is needed. Ray tracing resulted in a 2.5% increase in outcomes within 0.5D and 0.75D of target refraction, and a 10% increase in those coming within 1.00D.  
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;